Volume 19 Issue 3
Mar.  2021
Turn off MathJax
Article Contents
LIU Xin-xin, GAO Chun-ming, LIU Chuan-miao. Clinical characteristics of primary biliary cholangitis and RPR value in diagnosing cirrhosis[J]. Chinese Journal of General Practice, 2021, 19(3): 454-458. doi: 10.16766/j.cnki.issn.1674-4152.001834
Citation: LIU Xin-xin, GAO Chun-ming, LIU Chuan-miao. Clinical characteristics of primary biliary cholangitis and RPR value in diagnosing cirrhosis[J]. Chinese Journal of General Practice, 2021, 19(3): 454-458. doi: 10.16766/j.cnki.issn.1674-4152.001834

Clinical characteristics of primary biliary cholangitis and RPR value in diagnosing cirrhosis

doi: 10.16766/j.cnki.issn.1674-4152.001834
Funds:

 KJ2017A247

  • Received Date: 2020-09-11
    Available Online: 2022-02-19
  •   Objective  To investigate the clinical features of primary biliary cholangitis (PBC) and the value of red blood cell distribution width-to-platelet ratio (RPR) in diagnosing PBC progression to cirrhosis, as well as to improve the level of diagnosis and treatment of the disease by clinicians.  Methods  From January 2014 to December 2019, 61 patients were diagnosed as PBC in the Outpatient and Inpatient Department of the First Affiliated Hospital of Bengbu Medical College. The clinical data of the patients were retrospectively analysed. According to the diagnostic criteria of cirrhosis, it was divided into cirrhosis and non-cirrhosis groups. Blood routine, biochemical indices, RPR values, immunoglobulin, and complement levels were compared between the two groups. The diagnostic value of RPR for PBC cirrhosis was judged by the area under the working characteristic curve (AUC).  Results  Amongst the 61 patients with PBC, 47 were female (77.05%). The main clinical manifestations were jaundice (44.26%) and abdominal distension (24.59%). Sjogren's syndrome was the most common extrahepatic autoimmune disease. A total of 56 cases (91.80%) had abnormal liver function, primarily GGT increase. The positive rate of anti-mitochondrial antibody (AMA) and/or AMA-M2 was 93.44%. Significant differences were observed in RDW, PLT, RPR, and complement C3 and C4 between cirrhotic and non-cirrhotic groups. The AUC value of RPR in diagnosing liver cirrhosis was 0.705 (95% CI: 0.567-0.843; P=0.008). The best value was 0.471, and the sensitivity and specificity were 52.20% and 81.60%, respectively.  Conclusion  PBC usually occurs in middle-aged women, and jaundice is the most common clinical manifestation. The increase in ALP and GGT and the positive AMA are the main characteristics of the disease. Sjogren's syndrome is the most commonly associated extrahepatic autoimmune disease. RPR has a high specificity in diagnosing PBC progression to cirrhosis and can be combined with other non-invasive serological indicators to help evaluate the disease progress.

     

  • loading
  • [1]
    WANG L, GERSHWIN E M, WANG F S. Primary biliary cholangitis in China[J]. Curr Opin Gastroenterol, 2016, 32(3): 195-203. http://www.ncbi.nlm.nih.gov/pubmed/26885951
    [2]
    WANG H, XU H Q, WANG X M, et al. Red blood cell distribution width to platelet ratio is related to histologic severity of primary biliary cirrhosis[J]. Medicine(Baltimore), 2016, 95(11): e3114. http://www.scienceopen.com/document_file/5c0e919c-1c82-4eb7-bf2d-19764668cdd5/PubMedCentral/5c0e919c-1c82-4eb7-bf2d-19764668cdd5.pdf
    [3]
    HIRSCHFIELD G M, BEUERS U, CORPECHOT C, et al. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis[J]. J Hepatol, 2017, 67(1): 145-172. doi: 10.1016/j.jhep.2017.03.022
    [4]
    徐小元, 丁惠国, 李文刚, 等. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. doi: 10.3969/j.issn.1001-5256.2019.11.006
    [5]
    ABDULKARIM M, ZENOUZI R, SEBODE M, et al. Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis[J]. Scand J Gastroenterol, 2019, 54(11): 1391-1396. doi: 10.1080/00365521.2019.1683226
    [6]
    GATSELIS N K, GOET J C, ZACHOU K, et al. Factors associated with progression and outcomes of early stage primary biliary cholangitis[J]. Clin Gastroenterol Hepatol, 2020, 18(3): 684-692, 696. doi: 10.1016/j.cgh.2019.08.013
    [7]
    LOAEZA-DEL C A, GAYTAN-SANTILLAN A, LOPEZ-TELLO A, et al. Patterns of serum lipids derangements and cardiovascular risk assessment in patients with primary biliary cholangitis[J]. Ann Hepatol, 2019, 18(6): 879-882. doi: 10.1016/j.aohep.2019.07.006
    [8]
    鲁丹, 万彦彬, 杨小金, 等. 原发性胆汁性肝硬化合并自身免疫性疾病患者免疫学指标及补体水平研究[J]. 检验医学与临床, 2016, 13(13): 1829-1831. doi: 10.3969/j.issn.1672-9455.2016.13.032
    [9]
    TANG L, ZHONG R, HE X, et al. Evidence for the association between IgG-antimitochondrial antibody and biochemical response to ursodeoxycholic acid treatment in primary biliary cholangitis[J]. J Gastroenterol Hepatol, 2017, 32(3): 659-666. doi: 10.1111/jgh.13534
    [10]
    李京华, 赵伟, 童晶晶, 等. 原发性胆汁性肝硬化发生失代偿的危险因素研究[J]. 检验医学, 2018, 33(5): 399-403. https://www.cnki.com.cn/Article/CJFDTOTAL-SHYY201805006.htm
    [11]
    张帅, 郭冠亚, 周霞, 等. 原发性胆汁性胆管炎家系筛查及其低频突变的全外显子组测序研究[J]. 中华肝脏病杂志, 2018, 26(5): 388-392. doi: 10.3760/cma.j.issn.1007-3418.2018.05.014
    [12]
    CELIK D, TATAR B, KOSE S, et al. Evaluation of the diagnostic validity of noninvasive tests for predicting liver fibrosis stage in chronic hepatitis B patients[J]. Acta Gastroenterol Belg, 2020, 83(3): 419-425. http://www.researchgate.net/publication/345145444_Evaluation_of_the_diagnostic_validity_of_noninvasive_tests_for_predicting_liver_fibrosis_stage_in_chronic_hepatitis_B_patients
    [13]
    WANG H L, WANG J, XIA J, et al. Red cell distribution width to platelet ratio predicts liver fibrosis in patients with autoimmune hepatitis[J]. Medicine(Baltimore), 2020, 99(34): e21408. http://journals.lww.com/md-journal/Fulltext/2020/08210/Red_cell_distribution_width_to_platelet_ratio.12.aspx
    [14]
    申波, 蒋廷旺. RDW与RPR在原发性胆汁性胆管炎病理分期严重程度判定中的价值[J]. 国际检验医学杂志, 2020, 41(6): 751-754. doi: 10.3969/j.issn.1673-4130.2020.06.030
    [15]
    HUANG C Y, HAN W J, WANG C M, et al. Early prognostic utility of gp210 antibody-positive rate in primary biliary cholangitis: A meta-analysis[J]. Dis Markers, 2019, 2019: 9121207. http://www.ncbi.nlm.nih.gov/pubmed/31737133
    [16]
    YANG F, YANG Y, WANG Q, et al. The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210[J]. Aliment Pharmacol Ther, 2017, 45(5): 733-743. doi: 10.1111/apt.13927
    [17]
    卢慧, 张文. 抗着丝点抗体在多种疾病的临床意义[J]. 中华临床免疫和变态反应杂志, 2018, 12(6): 650-654. https://www.cnki.com.cn/Article/CJFDTOTAL-OZHL201806032.htm
    [18]
    CHEN C T, TSENG Y C, YANG C W, et al. Increased risks of spontaneous bacterial peritonitis and interstitial lung disease in primary biliary cirrhosis patients with concomitant sjogren syndrome[J]. Medicine(Baltimore), 2016, 95(2): e2537. http://www.onacademic.com/detail/journal_1000038709880210_2355.html
    [19]
    涂荣芳, 杨雪, 唐映梅. 原发性胆汁性胆管炎合并肝外自身免疫性疾病的研究进展[J]. 临床肝胆病杂志, 2020, 36(6): 1398-1401. doi: 10.3969/j.issn.1001-5256.2020.06.046
    [20]
    FAN X, MEN R, NI P, et al. Concomitant systemic lupus erythematosus might have a negative impact on the biochemical responses to treatment in patients with primary biliary cholangitis[J]. Clin Rheumatol, 2020, 39(3): 795-803. doi: 10.1007/s10067-019-04853-2
    [21]
    HARMS M H, VAN BUUREN H R, CORPECHOT C, et al. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis[J]. J Hepatol, 2019, 71(2): 357-365. doi: 10.1016/j.jhep.2019.04.001
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(4)

    Article Metrics

    Article views (185) PDF downloads(4) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return